A. Stewart Campbell
Vorstandsvorsitzender bei Axial Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Daniel Wolfe | M | 47 |
Synglyco, Inc.
 Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY. | - |
| Ronald Renaud | M | 55 |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 7 Jahre |
| Sarkis K. Mazmanian | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| James Blair | M | 84 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Richard H. Aldrich | M | 69 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Nora Frey | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 3 Jahre |
| Sarah J. Meibusch | F | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 3 Jahre |
| Jeffrey E. Young | M | 51 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Eric Forquenot de la Fortelle | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 5 Jahre |
| Sakae Asanuma | M | 57 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Makoto Ohori | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Scott Brun | M | 56 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 4 Jahre |
| Chris Meyer | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Steven Opal | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Federico Bolognani | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David H. Donabedian | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 5 Jahre |
| Mike Nazwaski | M | - |
Queen's University
| 5 Jahre |
| Michael T. R. List | M | 53 |
Queen's University
| 8 Jahre |
| Peter Heusel | M | - |
Queen's University
| 7 Jahre |
| David S. Wai | M | 52 |
Queen's University
| 5 Jahre |
| Steven Wood | M | - |
Queen's University
| 6 Jahre |
| Chris Gear | M | - |
Queen's University
| 7 Jahre |
| Adam Shah | M | - |
Queen's University
| 7 Jahre |
| Rob Barbara | M | - |
Queen's University
| 4 Jahre |
| Mark Armour | M | 53 |
Queen's University
| 4 Jahre |
| Mason Granger | M | - |
Queen's University
| 5 Jahre |
| Peter Williams | M | - |
Queen's University
| 4 Jahre |
| Joshua P. Kleban | M | 53 |
Queen's University
| 4 Jahre |
| Heather Allen | F | 56 |
Queen's University
| 4 Jahre |
| Brent Roland | M | - |
Queen's University
| 4 Jahre |
| Rafael Wagner | M | 50 |
Queen's University
| 4 Jahre |
| Chris Naprawa | M | - |
Queen's University
| 4 Jahre |
| Sean McKinley | M | 51 |
Queen's University
| 4 Jahre |
| Ann Driscoll | F | - |
Queen's University
| 4 Jahre |
| Brad Elberg | M | - |
Queen's University
| 4 Jahre |
| Ravi Dinesh Bhat | M | - |
Queen's University
| 4 Jahre |
| Zahrein bin Mohammed Redza | M | 59 |
Queen's University
| 1 Jahre |
| Yuet Pun Cheung | M | 52 |
Queen's University
| 4 Jahre |
| Patrick Keefe | M | - |
Queen's University
| 4 Jahre |
| Jzaneen Lalani | F | 51 |
Queen's University
| 4 Jahre |
| Daniel Kim | M | - |
Queen's University
| 2 Jahre |
| Stacy Petriuk | F | - |
Queen's University
| 4 Jahre |
| Marc McQuillen | M | - |
Queen's University
| 4 Jahre |
| Patrice Walch-Watson | F | - |
Queen's University
| 3 Jahre |
| Mike Dilworth | M | - |
Queen's University
| 4 Jahre |
| Oliver Blum | M | - |
Queen's University
| 5 Jahre |
| Kathryn McLaughlin | F | 52 |
Queen's University
| 4 Jahre |
| Kevin Reid | M | 52 |
Queen's University
| 4 Jahre |
| Shuang Xie | M | 55 |
Queen's University
| 4 Jahre |
| Erin Crowe | F | 53 |
Queen's University
| 4 Jahre |
| Derek Mendham | M | - |
Queen's University
| 4 Jahre |
| Chand Sooran | M | - |
Queen's University
| 2 Jahre |
| Stuart John Campbell | M | - |
Queen's University
| 4 Jahre |
| Nigel A. Lewis | M | - |
Queen's University
| 4 Jahre |
| Martin Pradier | M | - |
Queen's University
| 2 Jahre |
| Alex Baniczky | M | - |
Queen's University
| 4 Jahre |
| Duncan Middlemiss | M | 62 |
Queen's University
| 4 Jahre |
| Hing Keung Mak | M | 61 |
Queen's University
| 4 Jahre |
| Patrick M. Boucher | M | - |
Queen's University
| 3 Jahre |
| Kirby Michael O'Connor | M | - |
Queen's University
| 2 Jahre |
| Stu Kedwell | M | - |
Queen's University
| 5 Jahre |
| Stephen Thompson | M | 55 |
Queen's University
| 4 Jahre |
| David S. Finch | M | - |
Queen's University
| 4 Jahre |
| Tamara Steinberg | F | - |
Queen's University
| 3 Jahre |
| Jacques Simoneau | M | 66 |
Queen's University
| 3 Jahre |
| Jason Gerald Capello | M | 51 |
Queen's University
| 4 Jahre |
| Mark Selby | M | 58 |
Queen's University
| 4 Jahre |
| Robert Pollock | M | 54 |
Queen's University
| 4 Jahre |
| Steve Parsons | M | - |
Queen's University
| 4 Jahre |
| Guy Barry Caplan | M | - |
Queen's University
| 2 Jahre |
| Jeff Elliott | M | - |
Queen's University
| 4 Jahre |
| Amy Glading | F | - |
Queen's University
| 4 Jahre |
| Myles William Zyblock | M | - |
Queen's University
| 3 Jahre |
| Carolyn Susan Dennis | F | - |
Queen's University
| 4 Jahre |
| Dominique Barker | F | 52 |
Queen's University
| 5 Jahre |
| Joe Timlin | M | - |
Queen's University
| 4 Jahre |
| Paul McHugh | M | - |
St. Francis Xavier University
| 4 Jahre |
| Malcolm Stephen White | M | - |
Queen's University
| 4 Jahre |
| Shane Maine | M | - |
Queen's University
| 4 Jahre |
| Elizabeth A. McLemore | F | - |
Queen's University
| 4 Jahre |
| James G. McVicar | M | 58 |
Queen's University
| 4 Jahre |
| Brent Harris | M | - |
Queen's University
| 4 Jahre |
| John Donelson | M | 59 |
Queen's University
| 2 Jahre |
| Jonathan William Hunter | M | - |
Queen's University
| 4 Jahre |
| Anna Ladd-Kruger | F | 53 |
Queen's University
| 1 Jahre |
| Sheila Elizabeth Norman | F | - |
Queen's University
| 4 Jahre |
| Shannon C. Shaw | F | 53 |
Queen's University
| 4 Jahre |
| Tim Sun | M | 62 |
Queen's University
| 3 Jahre |
| Leslie F. Kende | M | - |
Queen's University
| 4 Jahre |
| Zohrab Mawani | M | - |
Queen's University
| 4 Jahre |
| Mark Usher | M | - |
Queen's University
| 2 Jahre |
| Gordon S. Bakarich | M | - |
Queen's University
| 4 Jahre |
| Yafan Huang | M | - |
Queen's University
| 3 Jahre |
| Hyong-Gue Bang | M | 50 |
Queen's University
| 4 Jahre |
| Ian Prittie | M | - |
Queen's University
| 4 Jahre |
| Lars G. Leckie | M | - |
Queen's University
| 4 Jahre |
| Nils Voermann | M | - |
Queen's University
| 4 Jahre |
| Alexander Clarke | M | - |
Queen's University
| 2 Jahre |
| James A. Mott | M | - |
Queen's University
| 3 Jahre |
| Jason Macfarlane | M | - |
Queen's University
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 84 | 84,00% |
| Vereinigte Staaten | 16 | 16,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- A. Stewart Campbell
- Persönliches Netzwerk